[17340] in Framemaker_Discussion
=?UTF-8?B?8J+SqiBSRUFMIEVYQ0xVU0lWRSBQUk9EVUNUUyDimYLvuI8=?=
daemon@ATHENA.MIT.EDU (=?UTF-8?B?UGhhcm1hY3kgMjR4NyAtIEZp)
Mon Feb 5 19:24:31 2024
To: eke090624@yahoo.com, rohit44798@gmail.com, aemacad@gmail.com,
nitinrechode@gmail.com, krishnabhowal1111@gmail.com,
dfouse@upscoinc.com, jsterk@goodloerealty.com, wsobczak@holycross.edu,
frame@mit.edu, jumbehauer@hncbank.com, esther.hilton@wellmont.org,
themasterbidmumen0791@gmail.com, jwatts@breitdrescher.com,
vinusalscott@fairleadcre.com, carlos.barreto@accolade.com,
vs1999925@gmail.com, ajaybawlekar007@gmail.com,
bansalsanjeev0026@gmail.com, taneka.blake@mascott.com,
zach.meyer@acuity.com, ma.rr.y.ali.c.ea.n.n0.1@gmail.com,
mholbrooks@morgan-corp.com, jignesgthakor@gmail.com,
sandhya.shenai@uchealth.com, barak@anchorbuildersmn.com,
daniyalmule@gmail.com, linda.potter@stelizabeth.com,
kevbourgeois58@gmail.com, amb25nox@whois-shield.com,
lisa.foley@evergreenhealth.com
From: =?UTF-8?B?UGhhcm1hY3kgMjR4NyAtIEZpbmFsIFByaWNl?= <Pharmacy24x7-FinalPrice@fkit.hr>
Reply-To: Pharmacy24x7-FinalPrice@fkit.hr
MIME-Version: 1.0
Content-Type: multipart/alternative; boundary="8df92351d6d6aa7d106d52c3464621c3"
Message-Id: <20240206002420.37D4E3007BC@pierre.fkit.hr>
Date: Tue, 6 Feb 2024 01:24:20 +0100 (CET)
--8df92351d6d6aa7d106d52c3464621c3
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: base64
R29vZCBhZnRlcm5vb24gbXkgZGFybGluZy5TdXBlciBGb3JjZSBQYWNrIC0gb25jZSB5b3UgaGF2
ZSBpdCwgeW91IGxvdmUgaXQuPEEgaHJlZj0iaHR0cHM6Ly9kZ3Nhcy5wYWdlLmxpbmsvNnZRWSI+
V09STERXSURFIFNUT1JFPC9BPg==
--8df92351d6d6aa7d106d52c3464621c3
Content-Type: text/html; charset=UTF-8
Content-Transfer-Encoding: base64
PEhUTUw+PEJPRFk+PFA+R29vZCBhZnRlcm5vb24gbXkgZGFybGluZy48L1A+PFA+U3VwZXIgRm9y
Y2UgUGFjayAtIG9uY2UgeW91IGhhdmUgaXQsIHlvdSBsb3ZlIGl0LjwvUD48UD48QSBocmVmPSJo
dHRwczovL2Rnc2FzLnBhZ2UubGluay82dlFZIj5XT1JMRFdJREUgU1RPUkU8L0E+PC9QPjwvQk9E
WT48L0hUTUw+
--8df92351d6d6aa7d106d52c3464621c3--
